• 主题
高级搜索  >
历史搜索 清空历史
首页> 中文期刊> 《中华医学杂志（英文版）》 >Comparison of Therapeutic Efficacy between Gastrectomy with Transarterial Chemoembolization Plus Systemic Chemotherapy and Systemic Chemotherapy Alone in Gastric Cancer with Synchronous Liver Metastasis

Comparison of Therapeutic Efficacy between Gastrectomy with Transarterial Chemoembolization Plus Systemic Chemotherapy and Systemic Chemotherapy Alone in Gastric Cancer with Synchronous Liver Metastasis

         
页面导航
  • 摘要
  • 著录项
  • 相关主题

摘要

Background:Systemic chemotherapy (SC) is the recommended treatment for gastric cancer with liver metastasis.However,the improvement in survival has been disappointing.The aim of this study was to compare the therapeutic efficacy of gastrectomy with transarterial chemoembolization plus SC (GTC) and SC alone for gastric cancer with synchronous liver metastasis.Methods:From January 2008 to December 2013,107 gastric cancer patients with synchronous liver metastasis attending the four participating centers were enrolled in this multicenter,ambispective,controlled cohort study.Patients who underwent GTC (n =32) were compared with controls who were received SC alone (n =75).The primary endpoints of the study were overall survival (OS) and progression-free survival (PFS).The secondary endpoints were response rate to treatment and treatment-related adverse effects.Results:The median OS was 14.0 months (95％ confidence interval [CI]:13.1-14.9 months) in the GTC treatment group and 8.0 months (95％ CI:6.6-9.4 months) in SC group,this difference being statistically significant (P ＜ 0.001).The median PFS was significantly longer in the GTC than in the SC group (5 months,95％ CI:2.2-7.8 months vs.3 months,95％ CI:2.3-3.4 months,respectively) (P ＜ 0.001).The rate of response to treatment was significantly better in the GTC than the SC group (59.4％ vs.37.4％,respectively) (P =0.035).According to multivariate analysis,OS in patients receiving combination treatment was significantly correlated with the size (P =0.037) and extent of liver metastases (P ＜ 0.001).PFS was also correlated with the extent of liver metastases (P =0.003).Conclusions:GTC is more effective than SC alone in patients with gastric cancer with synchronous liver metastasis.GTC therapy prolongs the survival of selected gastric cancer patients with synchronous liver metastasis.

著录项

  • 来源
    《中华医学杂志（英文版）》 |2015年第16期|2194-2201|共8页
  • 作者

    Sen-Feng Liu; Can-Rong Lu; Hai-Dong Cheng; Hong-Qing Xi; Jian-Xin Cui; Ji-Yang Li; Wei-Song Shen;

  • 作者单位

    Department of General Surgery,Chinese People's Liberation Army General Hospital,Beijing 100853,China;

    Department of General Surgery,Chinese People's Liberation Army General Hospital,Beijing 100853,China;

    Department of General Surgery,Chinese People's Liberation Army General Hospital,Beijing 100853,China;

    Department of General Surgery,Chinese People's Liberation Army General Hospital,Beijing 100853,China;

    Department of General Surgery,Chinese People's Liberation Army General Hospital,Beijing 100853,China;

    Department of General Surgery,Chinese People's Liberation Army General Hospital,Beijing 100853,China;

    Department of General Surgery,Chinese People's Liberation Army General Hospital,Beijing 100853,China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号